APTOF
Price
$3.00
Change
+$0.40 (+15.38%)
Updated
Apr 4 closing price
Capitalization
8.62M
LOGC
Price
$6.47
Change
-$0.00 (-0.00%)
Updated
Apr 7, 04:59 PM (EDT)
Capitalization
169.99M
Ad is loading...

APTOF vs LOGC

Header iconAPTOF vs LOGC Comparison
Open Charts APTOF vs LOGCBanner chart's image
Aptose Biosciences
Price$3.00
Change+$0.40 (+15.38%)
Volume$22.82K
Capitalization8.62M
ContextLogic
Price$6.47
Change-$0.00 (-0.00%)
Volume$7.03K
Capitalization169.99M
APTOF vs LOGC Comparison Chart
Loading...
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LOGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APTOF vs. LOGC commentary
Apr 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTOF is a StrongBuy and LOGC is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 08, 2025
Stock price -- (APTOF: $3.00 vs. LOGC: $6.47)
Brand notoriety: APTOF and LOGC are both not notable
APTOF represents the Biotechnology, while LOGC is part of the Internet Retail industry
Current volume relative to the 65-day Moving Average: APTOF: 0% vs. LOGC: 144%
Market capitalization -- APTOF: $8.62M vs. LOGC: $169.99M
APTOF [@Biotechnology] is valued at $8.62M. LOGC’s [@Internet Retail] market capitalization is $169.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The market cap for tickers in the [@Internet Retail] industry ranges from $1.81T to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B. The average market capitalization across the [@Internet Retail] industry is $37.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTOF’s FA Score shows that 0 FA rating(s) are green whileLOGC’s FA Score has 0 green FA rating(s).

  • APTOF’s FA Score: 0 green, 5 red.
  • LOGC’s FA Score: 0 green, 5 red.
According to our system of comparison, LOGC is a better buy in the long-term than APTOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTOF’s TA Score shows that 6 TA indicator(s) are bullish while LOGC’s TA Score has 4 bullish TA indicator(s).

  • APTOF’s TA Score: 6 bullish, 3 bearish.
  • LOGC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, APTOF is a better buy in the short-term than LOGC.

Price Growth

APTOF (@Biotechnology) experienced а -9.64% price change this week, while LOGC (@Internet Retail) price change was -6.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.36%. For the same industry, the average monthly price growth was -17.88%, and the average quarterly price growth was -17.48%.

The average weekly price growth across all stocks in the @Internet Retail industry was +24.53%. For the same industry, the average monthly price growth was +10.79%, and the average quarterly price growth was +0.04%.

Industries' Descriptions

@Biotechnology (-9.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Internet Retail (+24.53% weekly)

The internet retail industry includes companies that sell products and services through the Internet. With more and more consumers using online retailers, the companies have seen a big increase in the use of their services. Some of the companies in the group are focused on selling business-to-business products and services. Others sell business-to-consumer products and services. Internet retailers offer a wide variety of products like books, apparel, and electronics. Some companies even specialize in only one or two categories. One potentially critical factor for players to thrive in this space is the quality and speed of product delivery. This requires an investment in efficient distribution networks. Things like logistics are important factors in the success in the extremely competitive industry. For a company to stay relevant in the industry it must have effective pricing strategies and upgraded websites. The websites must be easy to navigate and engaging for customers. In addition to the revenues generated from straight sales, internet retailers can generate revenue from subscription fees and advertising. Amazon.com, Inc., Alibaba Group, and JD.com are some of the global leaders.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LOGC($170M) has a higher market cap than APTOF($8.62M). APTOF YTD gains are higher at: 1231.558 vs. LOGC (-8.037). APTOF has higher annual earnings (EBITDA): -24.82M vs. LOGC (-78M). LOGC has more cash in the bank: 149M vs. APTOF (3.32M). LOGC has less debt than APTOF: LOGC (0) vs APTOF (10.7M). LOGC has higher revenues than APTOF: LOGC (43M) vs APTOF (0).
APTOFLOGCAPTOF / LOGC
Capitalization8.62M170M5%
EBITDA-24.82M-78M32%
Gain YTD1231.558-8.037-15,324%
P/E RatioN/AN/A-
Revenue043M-
Total Cash3.32M149M2%
Total Debt10.7M0-
FUNDAMENTALS RATINGS
APTOF vs LOGC: Fundamental Ratings
APTOF
LOGC
OUTLOOK RATING
1..100
1250
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
46
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
3458
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LOGC's Valuation (46) in the Pharmaceuticals Major industry is somewhat better than the same rating for APTOF (90) in the Biotechnology industry. This means that LOGC’s stock grew somewhat faster than APTOF’s over the last 12 months.

LOGC's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as APTOF (100) in the Biotechnology industry. This means that LOGC’s stock grew similarly to APTOF’s over the last 12 months.

LOGC's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as APTOF (99) in the Biotechnology industry. This means that LOGC’s stock grew similarly to APTOF’s over the last 12 months.

APTOF's Price Growth Rating (34) in the Biotechnology industry is in the same range as LOGC (58) in the Pharmaceuticals Major industry. This means that APTOF’s stock grew similarly to LOGC’s over the last 12 months.

APTOF's P/E Growth Rating (100) in the Biotechnology industry is in the same range as LOGC (100) in the Pharmaceuticals Major industry. This means that APTOF’s stock grew similarly to LOGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APTOFLOGC
RSI
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
71%
Aroon
ODDS (%)
Bullish Trend 4 days ago
67%
N/A
View a ticker or compare two or three
Ad is loading...
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LOGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSPRX17.41-0.98
-5.33%
Morgan Stanley Inst Advantage C
EMSQX15.99-0.95
-5.61%
Shelton Emerging Markets Institutiona
VADDX65.62-3.94
-5.66%
Invesco Equally-Wtd S&P 500 Y
GFFDX69.31-4.52
-6.12%
Invesco Global Focus R5
SLASX34.06-2.26
-6.22%
Selected American Shares S

APTOF and

Correlation & Price change

A.I.dvisor tells us that APTOF and BDTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTOF and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTOF
1D Price
Change %
APTOF100%
+15.38%
BDTX - APTOF
30%
Poorly correlated
-7.28%
LOGC - APTOF
28%
Poorly correlated
-6.17%
MDGL - APTOF
28%
Poorly correlated
-3.89%
SLNO - APTOF
28%
Poorly correlated
-6.49%
HUMA - APTOF
27%
Poorly correlated
-6.90%
More

LOGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, LOGC has been closely correlated with EPIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if LOGC jumps, then EPIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LOGC
1D Price
Change %
LOGC100%
-6.17%
EPIX - LOGC
67%
Closely correlated
-6.33%
TSHA - LOGC
45%
Loosely correlated
-2.78%
PCVX - LOGC
45%
Loosely correlated
+3.40%
ATNM - LOGC
43%
Loosely correlated
-7.19%
LGND - LOGC
39%
Loosely correlated
-3.43%
More